Anti-DDC monoclonal antibody

Pre-made anti-DDC monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to DDC/DDC products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T62193-Ab-1/ GM-Tg-hg-T62193-Ab-2Anti-Human DDC monoclonal antibodyHuman
GM-Tg-rg-T62193-Ab-1/ GM-Tg-rg-T62193-Ab-2Anti-Rat DDC monoclonal antibodyRat
GM-Tg-mg-T62193-Ab-1/ GM-Tg-mg-T62193-Ab-2Anti-Mouse DDC monoclonal antibodyMouse
GM-Tg-cynog-T62193-Ab-1/ GM-Tg-cynog-T62193-Ab-2Anti-Cynomolgus/ Rhesus macaque DDC monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T62193-Ab-1/ GM-Tg-felg-T62193-Ab-2Anti-Feline DDC monoclonal antibodyFeline
GM-Tg-cang-T62193-Ab-1/ GM-Tg-cang-T62193-Ab-2Anti-Canine DDC monoclonal antibodyCanine
GM-Tg-bovg-T62193-Ab-1/ GM-Tg-bovg-T62193-Ab-2Anti-Bovine DDC monoclonal antibodyBovine
GM-Tg-equg-T62193-Ab-1/ GM-Tg-equg-T62193-Ab-2Anti-Equine DDC monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T62193-Ab-1/ GM-Tg-hg-T62193-Ab-2; GM-Tg-rg-T62193-Ab-1/ GM-Tg-rg-T62193-Ab-2;
GM-Tg-mg-T62193-Ab-1/ GM-Tg-mg-T62193-Ab-2; GM-Tg-cynog-T62193-Ab-1/ GM-Tg-cynog-T62193-Ab-2;
GM-Tg-felg-T62193-Ab-1/ GM-Tg-felg-T62193-Ab-2; GM-Tg-cang-T62193-Ab-1/ GM-Tg-cang-T62193-Ab-2;
GM-Tg-bovg-T62193-Ab-1/ GM-Tg-bovg-T62193-Ab-2; GM-Tg-equg-T62193-Ab-1/ GM-Tg-equg-T62193-Ab-2
Products NameAnti-DDC monoclonal antibody
Formatmab
Target NameDDC
Protein Sub-locationIntrocelluar Protein
Category of antibodyTherapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-DDC monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-T62193-Ag-1Recombinant multi-species DDC/ AADC protein
    ORF Viral VectorpGMLPm001636mouse Ddc Lentivirus plasmid
    ORF Viral VectorvGMLPm001636mouse Ddc Lentivirus particle


    Target information

    Target IDGM-T62193
    Target NameDDC
    Gene ID1644,13195,24311,693677,606852,101082989,280762,100052557
    Gene Symbol and SynonymsAADC,DDC
    Uniprot AccessionP20711,P14173,P27718
    Uniprot Entry NameDDC_HUMAN,DDC_RAT,DDC_BOVIN
    Protein Sub-locationIntrocelluar Protein
    CategoryTherapeutics Target
    DiseaseN/A
    Gene EnsemblENSG00000132437
    Target ClassificationN/A

    The target: DDC, gene name: DDC, also named as AADC. The encoded protein catalyzes the decarboxylation of L-3,4-dihydroxyphenylalanine (DOPA) to dopamine, L-5-hydroxytryptophan to serotonin and L-tryptophan to tryptamine. Defects in this gene are the cause of aromatic L-amino-acid decarboxylase deficiency (AADCD). AADCD deficiency is an inborn error in neurotransmitter metabolism that leads to combined serotonin and catecholamine deficiency. Multiple alternatively spliced transcript variants encoding different isoforms have been identified for this gene. [provided by RefSeq, Jun 2011].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.